insights_auto
Bakit tumaas ang ZLDPF 4.99%?
Tingnan ang Higit pang Detalyechevron_right
ZLDPF:OTCMKTS
Zealand Pharma A/S
$40.00
arrow_upward
+4.99%(+1.90) 1D
Okt 2, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ZLDPF...
Buksan
$36.80
Mataas
$40.00
Mababa
$36.80
Mkt. cap
2.74B
Avg. na dami
705.00
Dami
2.10K
Mataas nang 52-wk
$83.12
Mababa nang 52-wk
$35.93
Beta
1.23
Mga natitirang share
71.61M
Bilang ng mga empleyado
578
Buksan
$36.80
Mataas
$40.00
Mababa
$36.80
Mkt. cap
2.74B
Avg. na dami
705.00
Dami
2.10K
Mataas nang 52-wk
$83.12
Mababa nang 52-wk
$35.93
Beta
1.23
Mga natitirang share
71.61M
Bilang ng mga empleyado
578
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MedWatch
·
1 araw ang nakalipas
Zealand Pharma shares plunge after new survodutide data
Investing.com
·
1 araw ang nakalipas
Zealand Pharma shares fall 12% after obesity drug trial flags side effects
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Tungkol sa Zealand Pharma A/S